en mepolizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en otelixizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en siplizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en pexelizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en natalizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en teplizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en ocrelizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en toralizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en reslizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en visilizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en morolimumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en efalizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en rovelizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en ruplizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en talizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en rontalizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en gomiliximab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en priliximab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en fontolizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en teneliximab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en lumiliximab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en eculizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary | ||
en pascolizumab |
― DerivedFrom ⟶
Weight: 1.0
|
|
Source: English Wiktionary |